TGTX Operating Cash Flow Growth

Tg Therapeutics Inc · Operating Cash Flow Growth

TGTX logo

TGTX Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported130.23%
TGTX TTM Cash from Operations YoY % (36.84% → 130.23%)
High-resolution chart · PNG

TGTX operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Tg Therapeutics Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
130.2342%
77.1389%
38.8602%
-149.4944%
-187.1754%
-400.8826%
-28.9816%
33.2446%
142.3174%
112.1171%
82.1689%
82.4116%
41.0581%
40.8474%
40.4094%
8.2615%
-8.7303%
-21.0574%
-37.8202%
-35.1924%
-47.5027%
-44.6723%
-61.5191%
-41.7118%
-24.7473%
-20.3653%
-3.0103%
-16.2378%
-27.188%
-34.9018%
-37.5001%
-31.6603%
-31.5993%
-48.0273%
-52.235%
-54.756%
-52.9652%
-28.0836%
-37.8182%
-22.5398%
-19.8575%
-47.3644%
-27.4683%
-88.6264%
-146.5264%
-110.1286%
-223.9022%
-268.4148%
-109.1972%
-159.5035%
-108.6412%
-57.8641%
-449.8434%
-462.6073%
-5,892.312%
-503.6766%
-85.7924%
-0.7132%
95.6055%
59.6625%
43.3424%
-14.255%
-87.6657%
-6.885%
30.0718%
72.1946%
76.3772%
66.5301%
69.8737%
61.8498%
56.5578%
51.9607%
26.5488%
-16.5967%
-31.9837%
-20.9615%
-23.877%
-20.9856%
-24.1122%
-36.6945%
-26.4066%
-18.5143%
-9.7444%
-14.1833%
-34.1964%
-35.8428%
-64.8676%
-171.4649%
-196.4735%
-208.5504%
-140.9331%
-1.4522%
37.8967%
50.0357%
67.9828%
9.7607%
-12.6354%
12.5801%
-288.0471%
23.923%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.